Literature DB >> 21245776

Isolated nasal septum necrosis caused by Aspergillus flavus in an immunocompromised child.

Fouzia Naeem1, Jeffrey E Rubnitz, Hana Hakim.   

Abstract

Nontraumatic isolated nasal septal aspergillosis in the absence of sinusitis is a rare but serious infection in immunocompromised patients. Adequate management requires early diagnosis, prompt empiric antifungal therapy, and surgical debridement to prevent progression of life-threatening complications. With the increasing population of immunocompromised children, it is essential for timely management that clinicians have a high index of suspicion for this unusual presentation of aspergillosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245776      PMCID: PMC3873770          DOI: 10.1097/INF.0b013e31820b7c3a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.

Authors:  Liisa Hovi; Harri Saxen; Ulla M Saarinen-Pihkala; Kim Vettenranta; Taru Meri; Malcolm Richardson
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

2.  Fungal nasal septal abscess in the immunocompromised patient.

Authors:  Ron Walker; Laura Gardner; Raj Sindwani
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

3.  Nasal septal abscess in patients with immunosuppression.

Authors:  J M Debnam; A M Gillenwater; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-28       Impact factor: 3.825

4.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

5.  Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation.

Authors:  E Castagnola; E Furfaro; I Caviglia; M Licciardello; M Faraci; F Fioredda; P Tomà; R Bandettini; M Machetti; C Viscoli
Journal:  Clin Microbiol Infect       Date:  2010-02-11       Impact factor: 8.067

6.  Destruction of the nasal septum by aspergillus infection after autologous bone marrow transplantation.

Authors:  G K Siberry; C Costarangos; B A Cohen
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

7.  Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.

Authors:  François Boutboul; Corinne Alberti; Thierry Leblanc; Annie Sulahian; Eliane Gluckman; Francis Derouin; Patricia Ribaud
Journal:  Clin Infect Dis       Date:  2002-02-20       Impact factor: 9.079

8.  Aspergillosis of the nose and paranasal sinuses in immunocompromised children.

Authors:  L T Baydala; R Yanofsky; J Akabutu; W M Wenman
Journal:  CMAJ       Date:  1988-05-15       Impact factor: 8.262

9.  Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.

Authors:  Kieren A Marr; Michel Laverdiere; Anja Gugel; Wendy Leisenring
Journal:  Clin Infect Dis       Date:  2005-05-05       Impact factor: 9.079

10.  Nontraumatic nasal septal abscesses in the immunocompromised: etiology, recognition, treatment, and sequelae.

Authors:  S B Shah; A H Murr; K C Lee
Journal:  Am J Rhinol       Date:  2000 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.